Table of Contents
1. EXECUTIVE SUMMARY
1.1. Market Attractiveness Analysis
1.1.1. Global Animal Model Market, by Animal Type
1.1.2. Global Animal Model Market, by Technique
1.1.3. Global Animal Model Market, by Application
1.1.4. Global Animal Model Market, by End User
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Breakdown of Primary Respondents
3.5. Forecasting Techniques
3.6. Research Methodology for Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.2.1. R&D and Designing
5.2.2. Manufacturing
5.2.3. Distribution & Sales
5.2.4. Post Sales Services
5.3. Impact of COVID 19 on Animal Model Market
5.3.1. Impact on Market Value in 2020 and 2021
5.3.2. Clinical Trial Impact
5.3.3. Strategies to Overcome the challenges
5.3.4. Impact on Supply Chain
5.3.5. Impact on Pricing
6. GLOBAL ANIMAL MODEL MARKET, BY ANIMAL TYPE
6.1. Overview
6.2. Mice
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.3. Rats
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.4. Pigs
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.5. Rabbits
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.6. Others
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7. GLOBAL ANIMAL MODEL MARKET, BY TECHNIQUE
7.1. Overview
7.2. CRISPR
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.2.1. Microinjection
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.2.2. Electroporation
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.3. Others
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
8. GLOBAL ANIMAL MODEL MARKET, BY APPLICATION
8.1. Overview
8.2. Research and Development
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
8.2.1. Cardiovascular
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
8.2.2. Infectious Diseases
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
8.2.3. Metabolic Diseases
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
8.2.4. Immunological Diseases
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
8.2.5. Cancer
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
8.2.6. Diabetes
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
8.2.7. Genetic Diseases
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
8.2.8. Neurological Diseases
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
8.2.9. Others
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
8.3. Production and Quality Control
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
9. GLOBAL ANIMAL MODEL MARKET, BY END USER
9.1. Overview
9.2. Research Institutes
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
9.3. Educational Institutes
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
9.4. Pharmaceutical Companies
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
9.5. Contract Research Organizations
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
10. GLOBAL ANIMAL MODEL MARKET, BY REGION
10.1. Overview
10.2. Americas
10.2.1. North America
10.2.1.1. US
10.2.1.2. Canada
10.2.2. Latin America
10.3. Europe
10.3.1. Western Europe
10.3.1.1. Germany
10.3.1.2. France
10.3.1.3. Italy
10.3.1.4. Spain
10.3.1.5. UK
10.3.1.6. Rest of Western Europe
10.3.2. Eastern Europe
10.4. Asia-Pacific
10.4.1. Japan
10.4.2. China
10.4.3. India
10.4.4. Australia
10.4.5. South Korea
10.4.6. Rest of Asia-Pacific
10.5. Middle East & Africa
10.5.1. Middle East
10.5.2. Africa
11. COMPANY LANDSCAPE
11.1. Overview
11.2. Competitor Dashboard
11.3. Major Growth Strategy in the Global Animal Model Market
11.4. Competitive Benchmarking
11.5. The Leading Player in terms of Number of Developments in the Global Animal Model Market
11.6. Key Developments & Growth Strategies
11.6.1. New Product Launch/Service Deployment
11.6.2. Merger & Acquisition
11.6.3. Joint Ventures
11.7. Major Players Financial Matrix & Market Ratio
11.7.1. Sales & Operating Income 2019
11.7.2. Major Players R&D Expenditure 2019
12. COMPANY PROFILES
12.1. Janvier Labs
12.1.1. Company Overview
12.1.2. Products/Services Offered
12.1.3. Financial Overview
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Charles River Laboratories
12.3. GenOway S.A.
12.4. Envigo
12.5. Taconic Laboratories
12.6. Transgenic, Inc.
12.7. SAGE Labs
12.8. Horizon Discovery
12.9. Crown Bioscience Inc.
12.10. Harbor Antibodies Bv (A Subsidiary of Harbor BioMed)
12.11. Others
13. APPENDIX
13.1. References
13.2. Related Reports
NOTE:
This table of content is tentative and subject to change as the research progresses.
In section 12, only the top companies will be profiled. Each company will be profiled based on the Market Overview, Financials, Product Portfolio, Business Strategies, and Recent Developments parameters.
Please note: The financial details of the company cannot be provided if the information is not available in the public domain and or from reliable sources.
LIST OF TABLES
TABLE 1 GLOBAL ANIMAL MODEL MARKET SYNOPSIS, 2017–2027
TABLE 2 GLOBAL ANIMAL MODEL MARKET ESTIMATES & FORECAST, 2020–2027 (USD MILLION)
TABLE 3 GLOBAL ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 4 GLOBAL ANIMAL MODEL MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 5 GLOBAL ANIMAL MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 6 GLOBAL ANIMAL MODEL MARKET, BY END USERS, 2020–2027 (USD MILLION)
TABLE 7 GLOBAL ANIMAL MODEL MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 8 NORTH AMERICA: ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 9 NORTH AMERICA: ANIMAL MODEL MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 10 NORTH AMERICA: ANIMAL MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 11 NORTH AMERICA: ANIMAL MODEL MARKET, BY END USERS, 2020–2027 (USD MILLION)
TABLE 12 US: ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 13 US: ANIMAL MODEL MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 14 US: ANIMAL MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 15 US: ANIMAL MODEL MARKET, BY END USERS, 2020–2027 (USD MILLION)
TABLE 16 CANADA: ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 17 CANADA: ANIMAL MODEL MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 18 CANADA: ANIMAL MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 19 CANADA: ANIMAL MODEL MARKET, BY END USERS, 2020–2027 (USD MILLION)
TABLE 20 LATIN AMERICA: ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 21 LATIN AMERICA: ANIMAL MODEL MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 22 LATIN AMERICA: ANIMAL MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 23 LATIN AMERICA: ANIMAL MODEL MARKET, BY END USERS, 2020–2027 (USD MILLION)
TABLE 24 EUROPE: ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 25 EUROPE: ANIMAL MODEL MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 26 EUROPE: ANIMAL MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 27 EUROPE: ANIMAL MODEL MARKET, BY END USERS, 2020–2027 (USD MILLION)
TABLE 28 WESTERN EUROPE: ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 29 WESTERN EUROPE: ANIMAL MODEL MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 30
TABLE 31 WESTERN EUROPE: ANIMAL MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 32 WESTERN EUROPE: ANIMAL MODEL MARKET, BY END USERS, 2020–2027 (USD MILLION)
TABLE 33 EASTERN EUROPE: ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 34 EASTERN EUROPE: ANIMAL MODEL MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 35 EASTERN EUROPE: ANIMAL MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 36 EASTERN EUROPE: ANIMAL MODEL MARKET, BY END USERS, 2020–2027 (USD MILLION)
TABLE 37 ASIA-PACIFIC: ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 38 ASIA-PACIFIC: ANIMAL MODEL MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 39 ASIA-PACIFIC: ANIMAL MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 40 ASIA-PACIFIC: ANIMAL MODEL MARKET, BY END USERS, 2020–2027 (USD MILLION)
TABLE 41 MIDDLE EAST & AFRICA: ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 42 MIDDLE EAST & AFRICA: ANIMAL MODEL MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 43 MIDDLE EAST & AFRICA: ANIMAL MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 44 MIDDLE EAST & AFRICA: ANIMAL MODEL MARKET, BY END USERS, 2020–2027 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL ANIMAL MODEL MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL ANIMAL MODEL MARKET
FIGURE 4 GLOBAL ANIMAL MODEL MARKET SHARE, BY ANIMAL TYPE, 2018 (%)
FIGURE 5 GLOBAL ANIMAL MODEL MARKET SHARE, BY TECHNIQUE, 2018 (%)
FIGURE 6 GLOBAL ANIMAL MODEL MARKET SHARE, BY APPLICATION 2018 (%)
FIGURE 7 GLOBAL ANIMAL MODEL MARKET SHARE, BY END USERS, 2018 (%)
FIGURE 8 GLOBAL ANIMAL MODEL MARKET SHARE, BY REGION, 2018 (%)
FIGURE 9 AMERICAS: ANIMAL MODEL MARKET SHARE BY REGION, 2018 (%)
FIGURE 10 NORTH AMERICA: ANIMAL MODEL MARKET SHARE, BY COUNTRY, 2018 (%)
FIGURE 11 EUROPE: ANIMAL MODEL MARKET SHARE, BY REGION, 2018 (%)
FIGURE 12 WESTERN EUROPE: ANIMAL MODEL MARKET SHARE, BY COUNTRY, 2018 (%)
FIGURE 13 ASIA-PACIFIC: ANIMAL MODEL MARKET SHARE, BY COUNTRY, 2018 (%)
FIGURE 14 MIDDLE EAST & AFRICA: ANIMAL MODEL MARKET SHARE, BY COUNTRY, 2018 (%)
FIGURE 15 GLOBAL ANIMAL MODEL MARKET: COMPANY SHARE ANALYSIS, 2018 (%)
FIGURE 16 JANVIER LABS: KEY FINANCIALS
FIGURE 17 JANVIER LABS: SEGMENTAL REVENUE
FIGURE 18 JANVIER LABS: REGIONAL REVENUE
FIGURE 19 CHARLES RIVER LABORATORIES: KEY FINANCIALS
FIGURE 20 CHARLES RIVER LABORATORIES.: SEGMENTAL REVENUE
FIGURE 21 CHARLES RIVER LABORATORIES: REGIONAL REVENUE
FIGURE 22 GENOWAY S.A.: KEY FINANCIALS
FIGURE 23 GENOWAY S.A.: SEGMENTAL REVENUE
FIGURE 24 GENOWAY S.A.: REGIONAL REVENUE
FIGURE 25 ENVIGO: KEY FINANCIALS
FIGURE 26 ENVIGO: SEGMENTAL REVENUE
FIGURE 27 ENVIGO: REGIONAL REVENUE
FIGURE 28 TACONIC LABORATORIES: KEY FINANCIALS
FIGURE 29 TACONIC LABORATORIES: SEGMENTAL REVENUE
FIGURE 30 TACONIC LABORATORIES: REGIONAL REVENUE
FIGURE 31 TRANSGENIC, INC.: KEY FINANCIALS
FIGURE 32 TRANSGENIC, INC.: SEGMENTAL REVENUE
FIGURE 33 TRANSGENIC, INC.: REGIONAL REVENUE
FIGURE 34 SAGE LABS: KEY FINANCIALS
FIGURE 35 SAGE LABS: SEGMENTAL REVENUE
FIGURE 36 SAGE LABS: REGIONAL REVENUE
FIGURE 37 HORIZON DISCOVERY: KEY FINANCIALS
FIGURE 38 HORIZON DISCOVERY: SEGMENTAL REVENUE
FIGURE 39 HORIZON DISCOVERY: REGIONAL REVENUE
FIGURE 40 CROWN BIOSCIENCE INC.: KEY FINANCIALS
FIGURE 41 CROWN BIOSCIENCE INC.: SEGMENTAL REVENUE
FIGURE 42 CROWN BIOSCIENCE INC.: REGIONAL REVENUE
FIGURE 43 HARBOUR ANTIBODIES BV (A SUBSIDIARY OF HARBOUR BIOMED).: KEY FINANCIALS
FIGURE 44 HARBOUR ANTIBODIES BV (A SUBSIDIARY OF HARBOUR BIOMED).: SEGMENTAL REVENUE
FIGURE 45 HARBOUR ANTIBODIES BV (A SUBSIDIARY OF HARBOUR BIOMED).: REGIONAL REVENUE
$3,632.48 Million
7.8%
North America
2020-2027
動物モデルの市場規模は、2027年までに約3,632.48万米ドルの価値を保持すると予想され、2020年から2027年にかけて7.8%のCAGRを登録すると予測されています。
COVID19 分析
進行中の予測期間中に動物モデル市場が機能している主要な問題の1つは、損失を隠蔽し、コロナウイルスの影響を残すことです。パンデミックが世界的な境界にぶつかったため、堅固な医療施設とインフラを備えた先進国でさえ、苦しみ、苦戦しています。動物モデル市場の生産および製造部門は、活気に満ちた需要を満たすのに苦労してきましたが、パンデミックのみのために、動物モデル市場はサプライチェーンメカニズムの混乱という点で苦しんでいます。また、2021-2028年の予測期間中に世界政府によって課された封鎖は、動物モデル市場の期待される品質基準を満たすのに役立つ熟練労働者と専門家がいないため、サービスおよび生産部門を停止させています。
進行中の予測期間中、世界各国政府は、グローバルな研究開発イニシアチブへの投資に続いて、ローリングスキームと規制に関するサポートを強化してきました。また、コラボレーション、買収、合併、合弁事業は、競争の激しい市場のプレーヤーが地域および国際市場の発展において大きな役割を果たすのに役立ちます。市場のプレーヤーは、世界中のターゲットオーディエンスに利益をもたらすのに役立つ新製品を開発し、発売する可能性が高い。
マーケットダイナミクス
ドライバー
予測期間中の動物モデル市場の成長の主な理由の1つである研究開発分野の大幅な上昇がありました。業界の専門家は、2028年に終了する予測期間の主要な市場ドライバーとして機能する疾患検査と人間の生理学に関連する一連の職務を遂行するのに役立つ動物モデルの要件に大きな需要があると予測しています。
拘束
しかし、成長の機会がある場合には、制約や課題も生じます。予測された数値に従って動物モデル市場の成長を抑制する主要な問題の1つは、市場に関連する研究コストが非常に高く、市場のプレーヤーが実施および計画された運用を行うことを禁止する厳格な規制の枠組みがあることです。確実で決まった方法。
テクノロジー分析
検証や標的同定などの分野で役立つことで知られている動物モデルの精巧な使用の主なハイライトがありました。さらに、安全性スクリーニングや毒性、薬物スクリーニング、リードの最適化、薬物の有効性と安全性の前臨床分析などの分野での使用が認められています。これらの要因とともにテクノロジーの出現は、2028年に終了する予測期間中の傾向に基づいて、市場に優れた成長の機会を約束する可能性があります。また、特に2028年に終了する予測期間中に、世界中のさまざまな場所で遺伝学に基づく疾患の増加が大幅に増加しています。
研究目標
セグメントの概要
動物モデルの市場シェアは、ターゲットオーディエンスのニーズを満たす動物モデル市場セグメントの素晴らしいパフォーマンスにより、2021年から2028年の予測期間中に好調に向上する可能性があります。動物モデル市場は、以下に基づいて分割されています
。動物タイプ別:
動物モデル市場の動物型セグメントには、サル、猫、豚、マウスなどのペットが含まれます。
アプリケーション別:
動物モデル市場は、他のアプリケーションと同様に、学術、研究、開発、生産、品質管理などの一連のアプリケーションを扱っています。
地理的地域別:
さまざまなグローバル地域での市場サービスと製品に対する需要の高まりにより、4つの主要地域で市場が発展しています。リージョンは、北米、APAC リージョン、ヨーロッパ、その他の世界 (ROW) です。
地域分析
動物モデル市場分析は、資源の分配と多様な対象者のニーズの発展に基づいて、世界の成長は北米地域によって支配される可能性が高いと予測しています。この大規模な成長をもたらした主な理由の1つは、米国とカナダ政府によって導入された有利な政策の上昇が、研究開発活動におけるさまざまな資金計画の調達を支援していることです。また、注ぐ投資の数が大幅に増加しているため、動物モデル市場はこの地域で最大の速度で成長する可能性があります。
競争環境
競争の激化は、研究開発の増加とそれに続くさまざまな市場関係者からの投資の結果です。また、このレポートは、最近行われた開発に基づいて、プレーヤー間の競争力のある比較を引き出すことを目的としています。動物モデル市場のプレーヤーは次のとおりです。
最近の動向
対象読者
レポート概要
動物細胞の市場規模の成長は市場で議論されているため、レポートは詳細な議論のためにキュレーションされています。このレポートは、世界の動物モデル市場の機能を理解するのに役立ち、したがって、以下の要因について説明しています
。Report Attribute/Metric | Details |
---|---|
Market Size | 2027: USD 3,632.48 Million |
CAGR | 7.8% (2020-2027) |
Base Year | 2019 |
Forecast Period | 2027 |
Historical Data | 2018 |
Forecast Units | Value (USD Million) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | By Animal Type, Technology, Application, End-User, Region |
Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
Key Vendors | Janvier Labs (France), GenOway S.A. (France), Envigo (US), Charles River Laboratories (UK), Taconic Laboratories (UK), Transgenic, Inc. (Japan), SAGE Labs (US), Horizon Discovery (England), Crown Bioscience Inc. (US), Harbor Antibodies Bv (A Subsidiary of Harbor BioMed) (Massachusetts) |
Key Market Opportunities | The increasing innovation and research activity using mice model for immune diseases, cancer, rare disease, and other research activities boost the market growth |
Key Market Drivers |
|
Frequently Asked Questions (FAQ) :
Animal Model Market is projected to hold a substantial value of USD 3,632.48 million by the end of 2027.
Animal Model Market is expected to thrive at a CAGR of 7.8% by the end of 2027.
The growing research activity and increasing innovation of mice model for cancer, rare diseases, immune disease, and other R&D activities are likely to propel the global animal model market.
The global animal model market is estimated to be impeded due to the lack of expertise and strict rules and regulations on the use of animals in research.
The most established players of the global animal model market are Janvier Labs (France), Harbor Antibodies Bv (A Subsidiary of Harbor BioMed) (Massachusetts), Crown Bioscience Inc. (US), Horizon Discovery (England), SAGE Labs (US), Transgenic, Inc. (Japan), Taconic Laboratories (UK), Charles River Laboratories (UK), Envigo (US), and GenOway S. (France).